Industry News
AUT-Roche Diagnostics lab officially opens
AUT University has announced the opening of the AUT-Roche Diagnostics Laboratory in an example of the strong collaboration between the university and Roche Diagnostics - a partnership said to be the first of its kind in New Zealand. [ + ]
Evidence for the direct decay of the Higgs boson into fermions
Researchers at CERN have found evidence for the direct decay of the Higgs boson into fermions. This comes two years after the discovery of the particle and indicates that it behaves in the way the standard model of particle physics predicts. [ + ]
UQ student among 2014 Rolex Young Laureates
The 2014 Rolex Awards for Enterprise were announced this week at the Royal Society in London. Initiated in 1976, the awards program recognises enterprising men and women who are using their talents and initiative to change the world. [ + ]
Communication breakdown the cause of heart failure in muscular dystrophy
Research into muscular dystrophy has revealed a dysfunction in cell communication that causes heart failure in this disease. [ + ]
pSivida licensee gets Italian approval for Iluvien
pSivida (ASX:PVA) has revealed its licensee Alimera Sciences has secured Class C approval in Italy for diabetic macular oedema treatment Iluvien. [ + ]
Industry input to shape new medical technology strategy for Victoria
The Victorian Government has announced the development of a new strategy to position Victoria as an internationally competitive developer of medical technology (medtech), while also providing new opportunities for the state's advanced manufacturing sector. [ + ]
Public sector driving personalised medicine research
Public research bodies are responsible for the largest share of patent applications related to personalised medicine internationally, Marks & Clerk research shows. [ + ]
Minomic relocates HQ to Macquarie Uni Hospital
Minomic International has moved its scientific HQ to Macquarie University Hospital, to help commercialise prostate cancer test MiSat ELISA and jointly develop new cancer screening technologies. [ + ]
Targeting bacteria's antibiotic-resistant barrier
Scientists at the University of East Anglia (UEA) have discovered what they believe to be an Achilles heel in the defensive barrier which surrounds drug-resistant bacterial cells. [ + ]
Alchemia enrols first patient for new mCRC trial
Alchemia (ASX:ACL) has commenced recruitment for a clinical trial evaluating the use of HA-Irinotecan in combination with cetuximab in metastatic colorectal cancer. [ + ]
LBT completes $1.5m placement
LBT Innovations (ASX:LBT) has raised $1.5m through a private placement - and will seek another $1.5m in a share purchase plan - to help fund trials of its Automated Plate Assessment System. [ + ]
Patrys picks up third US patent for PAT-SM6
Patrys (ASX:PAB) has been awarded a third US patent covering its cancer treatment candidate PAT-SM6, which is in clinical trials as a treatment for multiple myeloma. [ + ]
Biotech student to showcase research in AbbVie Student Poster Awards
The AusBiotech 2014 national conference will feature a student poster display in the main exhibition hall for the duration of the conference, and the national winner of the AbbVie Student Poster Awards. [ + ]
Algae share insights into quantum biology
Algae that survive in environments with very low light use quantum mechanics to change the shape of a protein during photosynthesis and proposedly improve their energy uptake. [ + ]
Jumping genes and the rise of flowering plants
Scientists from Murdoch University have developed a theory of evolution that explains what Charles Darwin described as an "abominable mystery" - the rapid rise of flowering plants. [ + ]